Abametapir
ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
Also known as: Ha44, xeglyze
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Abametapir is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 2020. DrugCentral lists 4 molecular targets, including HDAC6, CCR5 and CCR8. Recorded indications include Pediculosis capitis.
- Approval status: ofm (first approved 2020 by the FDA).
- Molecular targets: HDAC6, CCR5, CCR8 and CCR1 (4 listed in DrugCentral).
- Indications: Pediculosis capitis.
- ATC code: P03AX07 (Other ectoparasiticides, incl. scabicides).
- Molecular formula: C12H12N2; molecular weight 184.24 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Pediculosis capitis
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histone deacetylase 6 | HDAC6 | unknown | IC50 5.99 |
| C-C chemokine receptor type 5 | CCR5 | unknown | EC50 5.64 |
| C-C chemokine receptor type 8 | CCR8 | unknown | EC50 5.12 |
| C-C chemokine receptor type 1 | CCR1 | unknown | EC50 4.80 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2020-07-24 | FDA | — | DR REDDYS LABS SA |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
P03AX07 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS › ECTOPARASITICIDES, INCL. SCABICIDES › Other ectoparasiticides, incl. scabicides |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Abametapir is on its molecule page.
| Molecular formula | C12H12N2 |
|---|---|
| Molecular weight | 184.24 g/mol |
| CAS number | 1762-34-1 |
| InChIKey | PTRATZCAGVBFIQ-UHFFFAOYSA-N |
| PubChem CID | 15664 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Abametapir used for?
DrugCentral lists the following indications for Abametapir: Pediculosis capitis.
How does Abametapir work?
Its molecular targets in DrugCentral include HDAC6, CCR5, CCR8 and CCR1.
When was Abametapir first approved?
Abametapir was first approved by the FDA in 2020.
What is the chemical formula of Abametapir?
Abametapir has the molecular formula C12H12N2 and a molecular weight of 184.24 g/mol.
Browse: all drugs starting with A · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 5403 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2205807 — compound record and bioactivity
- PubChem CID 15664 — chemical identifiers
- DrugBank DB11932 — drug record
- FDA UNII 6UO390AMFB — substance identity
- DailyMed: FDA labels for Abametapir — current prescribing information (label search)
- UniProt Q9UBN7 (HDAC6) — target protein
- UniProt P51681 (CCR5) — target protein
- UniProt P51685 (CCR8) — target protein
- UniProt P32246 (CCR1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.